These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24400077)

  • 1. Influence of GLP-1 on myocardial glucose metabolism in healthy men during normo- or hypoglycemia.
    Gejl M; Lerche S; Mengel A; Møller N; Bibby BM; Smidt K; Brock B; Søndergaard H; Bøtker HE; Gjedde A; Holst JJ; Hansen SB; Rungby J
    PLoS One; 2014; 9(1):e83758. PubMed ID: 24400077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes.
    Gejl M; Søndergaard HM; Stecher C; Bibby BM; Møller N; Bøtker HE; Hansen SB; Gjedde A; Rungby J; Brock B
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1165-9. PubMed ID: 22544917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low myocardial glucose uptake in Turner syndrome is unaffected by growth hormone: a randomized, placebo-controlled FDG-PET study.
    Trolle C; Hjerrild B; Mortensen KH; Knorr S; Søndergaard HM; Christiansen JS; Gravholt CH
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):133-40. PubMed ID: 25645325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study.
    Gormsen LC; Svart M; Thomsen HH; Søndergaard E; Vendelbo MH; Christensen N; Tolbod LP; Harms HJ; Nielsen R; Wiggers H; Jessen N; Hansen J; Bøtker HE; Møller N
    J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28242634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed response of insulin-stimulated fluorine-18 deoxyglucose uptake in glucose transporter-4-null mice hearts.
    Simões MV; Egert S; Ziegler S; Miyagawa M; Reder S; Lehner T; Nguyen N; Charron MJ; Schwaiger M
    J Am Coll Cardiol; 2004 May; 43(9):1690-7. PubMed ID: 15120832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes.
    Christensen M; Calanna S; Sparre-Ulrich AH; Kristensen PL; Rosenkilde MM; Faber J; Purrello F; van Hall G; Holst JJ; Vilsbøll T; Knop FK
    Diabetes; 2015 Jan; 64(1):72-8. PubMed ID: 25053587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial glucose uptake in patients with NIDDM and stable coronary artery disease.
    Mäki M; Nuutila P; Laine H; Voipio-Pulkki LM; Haaparanta M; Solin O; Knuuti JM
    Diabetes; 1997 Sep; 46(9):1491-6. PubMed ID: 9287051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hypoglycemia on myocardial susceptibility to ischemia-reperfusion injury and preconditioning in hearts from rats with and without type 2 diabetes.
    Pælestik KB; Jespersen NR; Jensen RV; Johnsen J; Bøtker HE; Kristiansen SB
    Cardiovasc Diabetol; 2017 Nov; 16(1):148. PubMed ID: 29121919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.
    Nauck MA; Heimesaat MM; Behle K; Holst JJ; Nauck MS; Ritzel R; Hüfner M; Schmiegel WH
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1239-46. PubMed ID: 11889194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of liraglutide on myocardial glucose uptake and blood flow in stable chronic heart failure patients: A double-blind, randomized, placebo-controlled LIVE sub-study.
    Nielsen R; Jorsal A; Iversen P; Tolbod LP; Bouchelouche K; Sørensen J; Harms HJ; Flyvbjerg A; Tarnow L; Kistorp C; Gustafsson I; Bøtker HE; Wiggers H
    J Nucl Cardiol; 2019 Apr; 26(2):585-597. PubMed ID: 28770459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of myocardial glucose uptake in patients with ischemic cardiomyopathy: application of a new quantitative method using regional tracer kinetic information.
    Wiggers H; Bøttcher M; Nielsen TT; Gjedde A; Bøtker HE
    J Nucl Med; 1999 Aug; 40(8):1292-300. PubMed ID: 10450680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-stimulated myocardial glucose uptake and the relation to perfusion and the nitric oxide system.
    Søndergaard HM; Bøttcher M; Schmitz O; Nielsen TT; Bøtker HE
    J Vasc Res; 2004; 41(1):38-45. PubMed ID: 14726631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis.
    Morita K; Katoh C; Yoshinaga K; Noriyasu K; Mabuchi M; Tsukamoto T; Kageyama H; Shiga T; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):806-12. PubMed ID: 15776232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-clinical myocardial metabolic alterations in chronic kidney disease.
    Fink JC; Lodge MA; Smith MF; Hinduja A; Brown J; Dinits-Pensy MY; Dilsizian V
    Cardiology; 2010; 116(3):160-7. PubMed ID: 20606430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1 inhibits blood-brain glucose transfer in humans.
    Lerche S; Brock B; Rungby J; Bøtker HE; Møller N; Rodell A; Bibby BM; Holst JJ; Schmitz O; Gjedde A
    Diabetes; 2008 Feb; 57(2):325-31. PubMed ID: 17991759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans.
    Iozzo P; Chareonthaitawee P; Di Terlizzi M; Betteridge DJ; Ferrannini E; Camici PG
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1163-71. PubMed ID: 11934683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts.
    Zhao T; Parikh P; Bhashyam S; Bolukoglu H; Poornima I; Shen YT; Shannon RP
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1106-13. PubMed ID: 16489128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain.
    Gejl M; Lerche S; Egefjord L; Brock B; Møller N; Vang K; Rodell AB; Bibby BM; Holst JJ; Rungby J; Gjedde A
    Front Neuroenergetics; 2013; 5():2. PubMed ID: 23543638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial pre-synaptic sympathetic function correlates with glucose uptake in the failing human heart.
    Mongillo M; John AS; Leccisotti L; Pennell DJ; Camici PG
    Eur J Nucl Med Mol Imaging; 2007 Aug; 34(8):1172-7. PubMed ID: 17294189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.